CDX-1401 (DEC-205/NY-ESO-1 fusion protein)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDX-1401 (DEC-205/NY-ESO-1 fusion protein), covering 2023-02-24 to 2023-02-24. Get the full timeline:
Most recent: Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission [Phase 1, Phase 2]